FACIT Expands with Expert Investment Committee to Grow its Oncology Portfolio

June 24, 2026 – FACIT’s new Investment and Asset Management Committee to provide strategic and expert advice on investment opportunities and advise on the growth and performance of FACIT’s portfolio.

Women-led health and biotech companies dominate FACIT’s latest investments

November 20, 2023 – On the globally-recognized Women’s Entrepreneurship Day, FACIT is pleased to announce investments in four breakthrough oncology innovations – all driven by women leaders. November 19th each year is a day to celebrate and showcase women’s contributions to advance communities and to strengthen their empowerment in the entrepreneurial ecosystem to drive economic impact. FACIT’s support of the four ventures, Virano Therapeutics, Hyivy Health, Tenomix Inc., and DTPx Therapeutics are representative of an asset portfolio where over one third are women-led or founded innovations, attracting one third of every dollar invested by FACIT – as much as ten times the average for the venture capital industry.